MIV-150/Zinc acetate

N/A

Report date: 2024/04/19 20:00:31

Base Information

Drug NameMIV-150/Zinc acetate
Drug Alias NameMIV-150+Zinc acetate dihydrateZinc acetate/MIV-150Zinc acetate+MIV-150MIV-150/Zinc acetate dihydratePC-1005
ClassificationSmall molecules
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes MIV-150Zinc acetate dihydrate
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedivir AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedivir ABNational Institute Of Allergy And Infectious Diseases (Niaid)Population Council, Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A